Axios | August 16, 2023
Just passing Medicare drug negotiations, an idea that Democrats pushed for almost 20 years against fierce pharma resistance, signals a “new chapter” in future legislative debates on drug pricing, said Zachary Baron, a health care law expert at Georgetown University’s O’Neill Institute.